AstraZeneca PLC closed 22.92% short of its 52-week high of £133.88, which the company reached on September 3rd.

The AstraZeneca PLC ADR AZN slid 2.83% to $64.87 Thursday, on what proved to be an all-around poor trading session for the ...

AstraZeneca Pharmaceuticals LP and a Christian sales specialist have agreed to settle his suit over the company’s failure to ...

Consider taking independent financial advice. Mark Hartley has positions in AstraZeneca Plc. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this ...

If you’re on the fence about investing in Corcept Therapeutics Incorporated or AstraZeneca PLC because you’re not sure how they measure up, it’s important to compare them on a few factors before ...

AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes for a potential blockbuster that could be part of a powerful ...

Biopharmaceutical multinational AstraZeneca is not letting a bumpy 2024 dictate its path forward in China, and in the wake of a recent controversy emerges a multibillion-dollar commitment to China ...

(Alliance News) - AstraZeneca PLC on Friday said it will establish a new global strategic research & development centre in Beijing. The Cambridge, England-based pharmaceutical company said it will ...

(Bloomberg) -- AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just months after the company’s top executive there was ...

In its fourth quarter 2024 investor letter, Parnassus Growth Equity Fund emphasized stocks such as AstraZeneca PLC (NASDAQ:AZN). AstraZeneca PLC (NASDAQ:AZN) is a biopharmaceutical company that ...